The independent platform for news, articles and advice for professionals in laboratory medicine

First NHS Trust to adopt Aiforia’s lung cancer model in clinical diagnostics

The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics. The duration of the contract is three years, with a possible three-year extension.

 

 

Aiforia previously announced in February a contract award allowing 25 NHS Trusts of the PathLAKE Plus consortium to purchase Aiforia artificial intelligence solutions in the UK. This contract award enables Trusts to purchase Aiforia solutions directly and to sign individual contracts without a separate tender process.

The CE-IVD marked Aiforia Clinical AI Model for Lung Cancer; PD-L1 is intended for use by pathologists in supporting them with the detection and calculation of PD-L1 biomarker levels in non-small cell lung cancer cases. The clinical grade deep learning artificial intelligence model can automatically detect tumour areas in a patient sample and calculate PD-L1 negative and positive cells.

“We are happy that the first NHS Trust has already signed a contract. The detection of PD-L1 presence in tumours is routinely used in clinical pathology as a predictive diagnostic test to identify which patients could potentially benefit from immunotherapy. It’s inspiring to think how AI can now assist pathologists in ensuring patients get the best possible care,” says Jukka Tapaninen, CEO of Aiforia. “We are ready to support these hospitals with training and implementation to facilitate the adoption of AI models in their clinical pathology department.”

 

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025